FMR LLC 13D and 13G filings for Arcutis Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-13 09:02 am Sale | 2023-11-10 | 13G | Arcutis Biotherapeutics, Inc. ARQT | FMR LLC | 3,551,261 3.771% | -5,587,912 (-61.14%) | Filing |
| 2023-02-09 08:23 am Purchase | 2023-02-09 | 13G | Arcutis Biotherapeutics, Inc. ARQT | FMR LLC | 9,139,173 14.999% | 1,594,961 (+21.14%) | Filing |
| 2022-02-09 09:09 am Purchase | 2022-02-08 | 13G | Arcutis Biotherapeutics, Inc. ARQT | FMR LLC | 7,544,212 14.999% | 999,048 (+15.26%) | Filing |
| 2021-02-08 10:15 am Purchase | 2021-02-05 | 13G | Arcutis Biotherapeutics, Inc. ARQT | FMR LLC | 6,545,164 14.999% | 2,486,155 (+61.25%) | Filing |
| 2020-02-10 12:29 pm Purchase | 2020-02-07 | 13G | Arcutis Biotherapeutics, Inc. ARQT | FMR LLC | 4,059,009 11.575% | 4,059,009 (New Position) | Filing |